Cariban 10 mg/10 mg cápsulas duras de liberación modificada clinical trials

A prospective, multicentre open-label clinical trial to evaluate the efficacy of the fixed-dose combination of Doxylamine and Pyridoxine 10/10 mg modified-release capsules on the quality of life of pregnant women presenting with nausea and vomiting of pregnancy (NVP).

This study looks at how well a medicine called Cariban, which combines two drugs (Doxylamine and Pyridoxine), helps pregnant women with morning sickness (nausea and vomiting). It focuses on how it improves their quality of life over 14 days.